Wed, Nov 6, 2024 12:13 PM
Kiran Vyapar Standalone September 2024 Net Sales at Rs 36.08 crore
A Flip by Shubhangi Gupta
Reported Standalone quarterly numbers for Pharmasia are: Net Sales at Rs 5.93 crore in September 2024 down 31.46% from Rs. 8.64 crore in September 2023. Quarterly Net Loss at Rs. 0.64 crore in September 2024 down 294.53% from Rs. 0.16 crore in September 2023. EBITDA stands negative at Rs. 0.56 crore in September 2024 down 700% from Rs. 0.07 crore in September 2023.
Open Flip
Two homegrown healthcare companies, backed by private equity firms General Atlantic and TPG, have received approval from capital markets regulator Securities and Exchange Board of India (SEBI) to go ahead with their initial public offerings. Draft papers filed by pharmaceutical contract research and development player (CRDMO) Sai Life Sciences, backed by TPG Capital.
Open Flip
Chief minister M K Stalin on Tuesday inaugurated a new IT park on the ELCOT (Electronics Corporation of Tamil Nadu) premises at Vilankurichi in the city.Spread over an area of 2.94 lakh sq ft and constructed at a cost of Rs 158.32 crore, the new IT park is expected to provide employment opportunities to 3,500 people.
Open Flip
